Hyperthyroidism caused by a germline activating mutation of the thyrotropin receptor gene: difficulties in diagnosis and therapy
R Bertalan, A Sallai, J Sólyom, G Lotz, I Szabó… - Thyroid, 2010 - liebertpub.com
Thyroid, 2010•liebertpub.com
Background: Germline activating mutations of the thyrotropin receptor (TSHR) gene have
been considered as the only known cause of sporadic nonautoimmune hyperthyroidism in
the pediatric population. Here we describe the long-term follow-up and evaluation of a
patient with sporadic nonautoimmune primary hyperthyroidism who was found to have a de
novo germline activating mutation of the TSHR gene. Summary: The patient was an infant
who presented at the age of 10 months in an unconscious state with exsiccation, wet skin …
been considered as the only known cause of sporadic nonautoimmune hyperthyroidism in
the pediatric population. Here we describe the long-term follow-up and evaluation of a
patient with sporadic nonautoimmune primary hyperthyroidism who was found to have a de
novo germline activating mutation of the TSHR gene. Summary: The patient was an infant
who presented at the age of 10 months in an unconscious state with exsiccation, wet skin …
Background: Germline activating mutations of the thyrotropin receptor (TSHR) gene have been considered as the only known cause of sporadic nonautoimmune hyperthyroidism in the pediatric population. Here we describe the long-term follow-up and evaluation of a patient with sporadic nonautoimmune primary hyperthyroidism who was found to have a de novo germline activating mutation of the TSHR gene.
Summary: The patient was an infant who presented at the age of 10 months in an unconscious state with exsiccation, wet skin, fever, and tachycardia. Nonautoimmune primary hyperthyroidism was diagnosed, and brain magnetic resonance imaging and computed tomography showed also Arnold-Chiari malformation type I. Continuous propylthiouracil treatment resulted in a prolonged clinical cure lasting for 10 years. At the age of 11 years and 5 months the patient underwent subtotal thyroidectomy because of symptoms of trachea compression caused by a progressive multinodular goiter. However, 2 months after surgery, hormonal evaluation indicated recurrent hyperthyroidism and the patient was treated with propylthiouracil during the next 4 years. At the age of 15 years the patient again developed symptoms of trachea compression. Radioiodine treatment resulted in a regression of the recurrent goiter and a permanent cure of hyperthyroidism without relapse during the last 3 years of his follow-up. Sequencing of exon 10 of the TSHR gene showed a de novo heterozygous germline I630L mutation, which has been previously described as activating mutation at somatic level in toxic thyroid nodules.
Conclusions: The I630L mutation of the TSHR gene occurs not only at somatic level in toxic thyroid nodules, but also its presence in germline is associated with nonautoimmune primary hyperthyroidism. Our case report demonstrates that in this disorder a continuous growth of the thyroid occurs without any evidence of elevated TSH due to antithyroid drug overdosing. This may justify previous recommendations for early treatment of affected patients with removal of as much thyroid tissue as possible.
Mary Ann Liebert